📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2 (2024)

First Author: Deliu N

Attributed to: Stratified adaptive therapeutic studies in pulmonary arterial hypertension caused by mutations in BMPR2 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-024-08485-z

Publication URI: http://dx.doi.org/10.1186/s13063-024-08485-z

Type: Journal Article/Review

Parent Publication: Trials

Issue: 1